4 Chronic Myeloid Leukemia Clinical Trials in Duarte, CA (2026)

Q: How do I join a clinical trial in Duarte?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Duarte research site will contact you.

Recruiting Chronic Myeloid Leukemia Studies in Duarte

NCT06423911Recruiting

Study of Olverembatinib (HQP1351) in Patients With CP-CML

A Global Multicenter, Open Label, Randomized, Phase 3 Registrational Study of Olverembatinib (HQP1351) in Patients with Chronic Phase Chronic Myeloid Leukemia (POLARIS-2)...

Duarte, CAPHASE3333 participantsAscentage Pharma Group Inc.

View Study Details

NCT03739814Recruiting

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

This phase II trial studies how well inotuzumab ozogamicin and blinatumomab with or without ponatinib work in treating patients with CD22-positive B-lineage acute lymphoblastic leukemia that is newly ...

Duarte, CAPHASE284 participantsNational Cancer Institute (NCI)

View Study Details

NCT07020533Recruiting

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

This phase Ib trial tests the safety, side effects, and how well cytomegalovirus (CMV)-modified vaccinia Ankara (MVA) Triplex vaccine works in enhancing CMV-specific immunity and preventing CMV viremi...

Duarte, CAPHASE146 participantsCity of Hope Medical Center

View Study Details

NCT07040982Recruiting

Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

This phase I trial tests the safety, side effects and best dose of asciminib as maintenance treatment for adults with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL) who have under...

Duarte, CAPHASE130 participantsCity of Hope Medical Center

View Study Details

About Chronic Myeloid Leukemia Clinical Trials in Duarte

Chronic myeloid leukemia (CML) is a type of cancer that starts in blood-forming cells of the bone marrow, characterized by the Philadelphia chromosome and BCR-ABL fusion gene. It was one of the first cancers treated successfully with targeted therapy. Tyrosine kinase inhibitors like imatinib have transformed CML into a manageable chronic condition.

There are currently 4 chronic myeloid leukemia clinical trials recruiting participants in Duarte, CA. These studies are seeking a combined 493 participants. Research is being sponsored by Ascentage Pharma Group Inc., National Cancer Institute (NCI), City of Hope Medical Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Myeloid Leukemia Clinical Trials in Duarte — FAQ

Are there chronic myeloid leukemia clinical trials in Duarte?

Yes, there are 4 chronic myeloid leukemia clinical trials currently recruiting in Duarte, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Duarte?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Duarte research site will contact you about next steps.

Are clinical trials in Duarte free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Duarte studies also compensate for your time and travel.

What chronic myeloid leukemia treatments are being tested?

The 4 active trials in Duarte are testing new therapies including novel drugs, biologics, and treatment approaches for chronic myeloid leukemia.

Data updated October 15, 2026 from ClinicalTrials.gov